PharmaLundensis AB
Investor
PharmaLundensis AB
Description
PharmaLundensis AB (publ) develops the following projects:
* A new, effective treatment for chronic obstructive pulmonary disease, COPD and chronic bronchitis.
* EcoFilterĀ® to eliminate the release of antibiotics in hospital waste water.
* Zero-concentrate evaporator technology.
* A new, effective treatment for chronic obstructive pulmonary disease, COPD and chronic bronchitis.
* EcoFilterĀ® to eliminate the release of antibiotics in hospital waste water.
* Zero-concentrate evaporator technology.
PharmaLundensis AB
Address
ScheelevƤgen 22, 223 63 Lund
Lund, Sweden
Lund, Sweden
Contact
info@pharmalundensis.se
Description
PharmaLundensis AB (publ) develops the following projects:
* A new, effective treatment for chronic obstructive pulmonary disease, COPD and chronic bronchitis.
* EcoFilterĀ® to eliminate the release of antibiotics in hospital waste water.
* Zero-concentrate evaporator technology.
* A new, effective treatment for chronic obstructive pulmonary disease, COPD and chronic bronchitis.
* EcoFilterĀ® to eliminate the release of antibiotics in hospital waste water.
* Zero-concentrate evaporator technology.
Matchmaking
Connect with PharmaLundensis AB
This entity is yours?
Update informationPosition on the value chain
With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.
Bio-resources and biobanking
- Cells, tissues and humanized xeno-organs
- Biosamples
- Viral, phage or bacterial specimen
Identification of biotherapies
- Target identification
- Target validation
- Screening
Drug design
- Drug assessment
- Drug engineering
- In vitro preclinical studies
Clinical validation
- Clinical trials
- In vivo preclinical validation
- Pre-industrial scale production
Production
- Upstream processes
- Downstream processes
- Quality control
Market access
- CE mark / market authorisation
- Payment / Reimbursement
- Care pathways